刘洁;罗毅鑫;刘兆睿;刘跃华;张薇;卢朝辉;
LIU Jie;LUO Yi-xin;LIU Zhao-rui;LIU Yue-hua;ZHANG Wei;LU Zhao-hui;Department of Dermatology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Dermatology, Leiden University Medical Center;Department of Hematology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Pathology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Uni

• 1:中国医学科学院北京协和医学院北京协和医院皮肤科
• 2:莱顿大学医学中心皮肤科
• 3:中国医学科学院北京协和医学院北京协和医院血液内科
• 4:中国医学科学院北京协和医学院北京协和医院病理科

摘要(Abstract)：

原发性皮肤淋巴瘤(primary cutaneous lymphoma,PCL)是一类结外非霍奇金淋巴瘤,具有独特的临床表现和组织病理学特征。2005年世界卫生组织-欧洲癌症研究和治疗组织(World Health Organization-European Organization for Research and Treatment of Cancer,WHO-EORTC)发表的PCL分类是该病的重要诊断标准和分类依据。随着研究进展,2018年WHO-EORTC更新了PCL分类,新增了慢性活动性EB病毒感染、原发性皮肤肢端CD8~+T细胞淋巴瘤、EB病毒阳性皮肤黏膜溃疡3种PCL类型,并对部分PCL的亚型进行了修订,其中涉及淋巴瘤样丘疹病、原发性皮肤边缘区淋巴瘤、原发性皮肤CD4~+小/中T细胞淋巴组织增殖性疾病等亚型。本文对PCL WHO-EORTC分类的最新进展进行解读。
Primary cutaneous lymphomas(PCL) are a group of non-Hodgkin's lymphomas that are presented with specific clinical manifestations and histopathological characteristics. The classification of PCL published by World Health Organization-European Organization for Research and Treatment of Cancer(WHO-EORTC) in 2005 was the important diagnostic criteria and classification basis for cutaneous lymphomas. With research progression, WHO-EORTC updated the classification of PCL in 2018, adding three subtypes of PCL, namely, chronic active Epstein Barr virus(EBV) infection, primary cutaneous acral CD8~+ T-cell lymphoma, and EBV-positive mucocutaneous ulcer. Besides, some subtypes of PCL were revised, including lymphomatoid papulosis, primary cutaneous marginal zone lymphoma, and primary cutaneous CD4~+ small/medium T cell lymphoproliferative disease. This article interprets the update of WHO-EORTC classification of PCL.

关键词(KeyWords)： 原发性皮肤淋巴瘤;T细胞淋巴瘤;B细胞淋巴瘤;结外NK/T细胞淋巴瘤
primary cutaneous lymphoma;T-cell lymphoma;B-cell lymphoma;extranodal NK/T-cell lymphoma

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划资助项目(2016YFC0901500);; 北京市自然科学基金(7182127)~~

作者(Author): 刘洁;罗毅鑫;刘兆睿;刘跃华;张薇;卢朝辉;
LIU Jie;LUO Yi-xin;LIU Zhao-rui;LIU Yue-hua;ZHANG Wei;LU Zhao-hui;Department of Dermatology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Dermatology, Leiden University Medical Center;Department of Hematology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Pathology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Uni

Email:

DOI:

参考文献(References)：

• [1] Willemze R,Jaffe ES,Burg G,et al.WHO-EORTC classification for cutaneous lymphomas[J].Blood,2005,105:3768- 3785.
• [2] Elder DE,Massi D,Scolyer RA,et al.WHO Classification of Skin Tumours[M].4th ed.France:IARC Press,2018.
• [3] Tokura Y,Ishihara S,Tagawa S,et al.Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma[J].J Am Acad Dermatol,2001,45:569- 578.
• [4] Rodriguez-Pinilla SM,Barrionuevo C,Garcia J,et al.EBV-associated cutaneous NK/T-cell lymphoma:review of a series of 14 cases from peru in children and young adults[J].Am J Surg Pathol,2010,34:1773- 1782.
• [5] Cho KH,Lee SH,Kim CW,et al.Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption:an analysis of six cases[J].Br J Dermatol,2004,151:372- 380.
• [6] 王诗琪,池诚,刘洁.皮肤T细胞淋巴瘤局部用药和物理治疗的研究进展[J].协和医学杂志,2019,10:157- 161.[6] Wang SQ,Chi C,Liu J.Advance in the Topical Medication and Physical Therapy for Cutaneous T Cell Lymphoma[J].Xie He Yi Xue Za Zhi,2019,10:157- 161.
• [7] Kimura H,Ito Y,Kawabe S,et al.EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts:prospective analysis of 108 cases[J].Blood,2012,119:673- 686.
• [8] Miyake T,Yamamoto T,Hirai Y,et al.Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites[J].Br J Dermatol,2015,172:56- 63.
• [9] Tokura Y,Ishihara S,Tagawa S,et al.Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma[J].J Am Acad Dermatol,2001,45:569- 578.
• [10] Petrella T,Maubec E,Cornillet-Lefebvre P,et al.Indolent CD8-positive lymphoid proliferation of the ear:a distinct primary cutaneous T-cell lymphoma?[J].Am J Surg Pathol,2007,31:1887- 1892.
• [11] Perry AM,Warnke RA,Hu Q,et al.Indolent T-cell lymphoproliferative disease of the gastrointestinal tract[J].Blood,2013,122:3599- 3606.
• [12] Tabanelli V,Valli R,Righi S,et al.A unique case of an indolent myometrial T-cell lymphoproliferative disorder with phenotypic features resembling uterine CD8+ resident memory T cells[J].Pathobiology,2014,81:176- 182.
• [13] Alberti-Violetti S,Fanoni D,Provasi M,et al.Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement:A long-standing case with an unexpected progression[J].J Cutan Pathol,2017,44:964- 968.
• [14] Dojcinov SD,Venkataraman G,Pittaluga S,et al.Age-related EBV-associated lymphoproliferative disorders in the Western population:a spectrum of reactive lymphoid hyperplasia and lymphoma[J].Blood,2011,117:4726- 4735.
• [15] Dojcinov SD,Venkataraman G,Raffeld M,et al.EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression[J].Am J Surg Pathol,2010,34:405- 417.
• [16] Kumar S,Fend F,Quintanilla-Martinez L,et al.Epstein-Barr virus-positive primary gastrointestinal Hodgkin’s disease:association with inflammatory bowel disease and immunosuppression[J].Am J Surg Pathol,2000,24:66- 73.
• [17] Natkunam Y,Goodlad JR,Chadburn A,et al.EBV-Positive B-Cell Proliferations of Varied Malignant Potential:2015 SH/EAHP Workshop Report-Part 1[J].Am J Clin Pathol,2017,147:129- 152.
• [18] Saggini A,Gulia A,Argenyi Z,et al.A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.Description of 9 cases[J].Am J Surg Pathol,2010,34:1168- 1175.
• [19] Kempf W,Kazakov DV,Scharer L,et al.Angioinvasive lymphomatoid papulosis:a new variant simulating aggressive lymphomas[J].Am J Surg Pathol,2013,37:1- 13.
• [20] Karai LJ,Kadin ME,Hsi ED,et al.Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis[J].Am J Surg Pathol,2013,37:1173- 1181.
• [21] van Maldegem F,van Dijk R,Wormhoudt TA,et al.The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment[J].Blood,2008,112:3355- 3361.
• [22] Edinger JT,Kant JA,Swerdlow SH.Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets[J].Am J Surg Pathol,2010,34:1830- 1841.
• [23] Swerdlow SH.Cutaneous marginal zone lymphomas[J].Semin Diagn Pathol,2017,34:76- 84.